TABLE OF CONTENTS Volume 6, Number 5, September 2019 Neurology.org/NN

Editor’s Corner

e601 Neurofilament light chain levels in MS: At thedoorstep of clinical applicationJ. Dalmau

Open Access

Editorial

e599 Blood neurofilament light chain at the doorstep ofclinical applicationD. Leppert and J. Kuhle

Open Access Companion article, p. e598

Articles

e598 High serumneurofilament light chain normalizes afterhematopoietic stem cell transplantation for MSS. Thebault, D.R. Tessier, H. Lee,M. Bowman, A. Bar-Or, D.L. Arnold,H.L. Atkins, V. Tabard-Cossa, and M.S. Freedman

Open Access Editorial, p. e599 Class of Evidence

e583 Collaborative International Research in Clinical andLongitudinal Experience Study in NMOSDL.J. Cook, J.W. Rose, J.S. Alvey, A.M. Jolley, R. Kuhn, B. Marron,M. Pederson, R. Enriquez, J. Yearley, S. McKechnie, M.H. Han,A.J. Tomczak, M. Levy, M.A. Mealy, J. Coleman, J.L. Bennett,R. Johnson, M. Barnes-Garcia, A.L. Traboulsee, R.L. Carruthers,L.E. Lee, J.J. Schubert, K. McMullen, I. Kister, Z. Rimler, A. Reid,N.L. Sicotte, S.M. Planchon, J.A. Cohen, D. Ivancic, J.L. Sedlak,I.K. Sand, P. Repovic, L. Amezcua, A. Pruitt, E. Amundson, T. Chitnis,D.S. Mullin, E.C. Klawiter, A.W. Russo, C.S. Riley, K.B. Onomichi,L. Levine, K.E. Nelson, N.M. Nealon, C. Engel, M. Kruse-Hoyer,M. Marcille, L. Tornes, A. Rumpf, A. Greer, M. Kenneally Behne,R.R. Rodriguez, D.W. Behne, D.W. Blackway, B. Coords,T.F. Blaschke, J. Sheard, T.J. Smith, J.M. Behne, and M.R. Yeaman,on behalf of The Guthy-Jackson Charitable FoundationInternational Clinical Consortium (GJCF–ICC)

Open Access

e584 Does CSF pleocytosis have a predictive value fordisease course in MS?I. Lotan, F. Benninger, R. Mendel, M.A. Hellmann, andI. Steiner

Open Access

e586 Randomized, controlled crossover study of IVIg fordemyelinating polyneuropathy and diabetesA. Breiner, C. Barnett Tapia, L.E. Lovblom, B.A. Perkins,H.D. Katzberg, and V. Bril

Open Access Class of Evidence

e587 Gray matter microglial activation in relapsing vsprogressive MS: A [F-18]PBR06-PET studyT. Singhal, K. O’Connor, S. Dubey, H. Pan, R. Chu, S. Hurwitz,S. Cicero, S. Tauhid, D. Silbersweig, E. Stern, M. Kijewski, M. DiCarli,H.L. Weiner, and R. Bakshi

Open Access

e588 Systemic inflammatory response syndrome andlong-term outcome after intracerebralhemorrhageM. Hagen, J.A. Sembill, M.I. Sprugel, S.T. Gerner, D. Madzar,H. Lucking, P. Holter, S. Schwab, H.B. Huttner, and J.B. Kuramatsu

Open Access

e590 Long-term safety and efficacy of subcutaneousimmunoglobulin IgPro20 in CIDP: PATHextension studyI.N. van Schaik, O. Mielke, V. Bril, N. van Geloven, H.-P. Hartung,R.A. Lewis, G. Sobue, J.-P. Lawo, M. Praus, B.L. Durn,D.R. Cornblath, and I.S.J. Merkies, on behalf of the PATHstudy group

Open Access Class of Evidence

e591 Pharmacokinetics and pharmacodynamics ofnatalizumab in pediatric patients with RRMSA. Ghezzi, G. Comi, L.M. Grimaldi, L. Moiola, C. Pozzilli,S. Fantaccini, and P. Gallo

Open Access Class of Evidence

Continued

e592 Novel clinical features of glycine receptor antibodysyndrome: A series of 17 casesA.L. Piquet, M. Khan, J.E.A. Warner, M.P. Wicklund, J.L. Bennett,M.A. Leehey, L. Seeberger, T.L. Schreiner, M.M. Paz Soldan, andS.L. Clardy

Open Access

e593 Lesion activity and chronic demyelination are themajor determinants of brain atrophy in MSC. Wang, M.H. Barnett, C. Yiannikas, J. Barton, J. Parratt, Y. You,S.L. Graham, and A. Klistorner

Open Access

e594 Hepatitis E virus infections in patients with MS onoral disease-modifying treatmentM. Diebold, B. Fischer-Barnicol, C. Tsagkas, J. Kuhle, L. Kappos,T. Derfuss, and B.F. Decard

Open Access

e595 Intrathecal B-cell accumulation and axonal damagedistinguish MRI-based benign from aggressiveonset in MSS. Engel, M. Friedrich, M. Muthuraman, F. Steffen, A. Poplawski,S. Groppa, S. Bittner, F. Zipp, and F. Luessi

Open Access

e596 Relationship between retinal inner nuclear layer,age, and disease activity in progressive MSM. Cellerino, C. Cordano, G. Boffa, G. Bommarito, M. Petracca,E. Sbragia, G. Novi, C. Lapucci, E. Capello, A. Uccelli, and M. Inglese

Open Access

e597 Cholecalciferol in relapsing-remitting MS:A randomized clinical trial (CHOLINE)W. Camu, P. Lehert, C. Pierrot-Deseilligny, P. Hautecoeur,A. Besserve, A.-S. Jean Deleglise, M. Payet, E. Thouvenot, andJ.C. Souberbielle

Open Access Class of Evidence

e603 Anti–pan-neurofascin IgG3 as a marker of fulminantautoimmune neuropathyH. Stengel, A. Vural, A.-M. Brunder, A. Heinius, L. Appeltshauser,B. Fiebig, F. Giese, C. Dresel, A. Papagianni, F. Birklein, J. Weis,T. Huchtemann, C. Schmidt, P. Kortvelyessy, C. Villmann, E. Meinl,C. Sommer, F. Leypoldt, and K. Doppler

Open Access

Clinical/Scientific Notes

e589 Tumefactive demyelination in a patient withrelapsing-remitting MS on ocrelizumabV.F. Moreira Ferreira, D. Meredith, and J.M. Stankiewicz

Open Access

e600 Peripherally derived macrophages as majorphagocytes in MOG encephalomyelitisY.N. Kwon, P.J. Waters, M. Kim, Y.S. Choi, J.W. Kim, J.-J. Sung,S.-H. Park, and S.-M. Kim

Open Access

e602 Chronic inflammatory demyelinatingpolyneuropathy associated with contactin-1antibodies in a childL. Carrera-Garcıa, D. Natera-de Benito, C. Lleixa, C. Ortez,J. Colomer, A. Nascimento, A. Saiz, J. Dalmau, L. Querol, andT. Armangue

Open Access

Cover imageThe upper panels show in a cell based assay the reactivity of a commercialcontactin 1 antibody (green) and patient’s serum (red) with contactin 1expressed in HEK cells. The colocalization of reactivities is shown in theright panel. The lower panels show the reactivity of a panNeurofascincommercial antibody (green) and patients’ serum (red) with theparanodal region of pig teased nerve fibers. The colocalization ofreactivities is shown in the right panel.See page e602

TABLE OF CONTENTS Volume 6, Number 5, September 2019 Neurology.org/NN

Academy OfficersJames C. Stevens, MD, FAAN, PresidentOrly Avitzur, MD, MBA, FAAN, President ElectAnn H. Tilton, MD, FAAN, Vice PresidentCarlayne E. Jackson, MD, FAAN, SecretaryJanis M. Miyasaki, MD, MEd, FRCPC, FAAN, TreasurerRalph L. Sacco, MD, MS, FAAN, Past President

Executive Office, American Academy of NeurologyCatherine M. Rydell, CAEChief Executive Officer201 Chicago AveMinneapolis, MN 55415Tel: 612-928-6100

Editorial OfficePatricia K. Baskin, MS, Executive EditorKathleen M. Pieper, Senior Managing Editor, NeurologySharon L. Quimby, Managing Editor, Neurology® Clinical PracticeMorgan S. Sorenson, Managing Editor, Neurology® Neuroimmunology& Neuroinflammation

Lee Ann Kleffman, Managing Editor, Neurology® GeneticsAndrea Rahkola, Production Editor, NeurologyRobert J. Witherow, Senior Editorial AssociateKaren Skaja, Senior Editorial AssociateKaitlyn Aman Ramm, Editorial AssistantKristen Swendsrud, Editorial AssistantJustin Daugherty, Editorial AssistantMadeleine Sendek, MPH, Editorial Assistant

PublisherWolters KluwerBaltimore, MD

Publishing StaffKim Jansen, Executive PublisherJessica Heise, Production Team Leader, Neurology JournalsMegen Miller, Production EditorStacy Drossner, Production Associate

Neurology® is a registered trademark of the American Academy of Neurology(registration valid in the United States).

Neurology® Neuroimmunology & Neuroinflammation (eISSN 2332-7812) is anopen access journal published online for the American Academy of Neurology,201 Chicago Ave, Minneapolis, MN 55415, by Wolters Kluwer Health, Inc. at14700 Citicorp Drive, Bldg 3, Hagerstown, MD 21742. Business offices arelocated at Two Commerce Square, 2001 Market St., Philadelphia, PA 19103.Production offices are located at 351 West Camden Street, Baltimore, MD21201-2436. © 2019 American Academy of Neurology.

Neurology® Neuroimmunology & Neuroinflammation is an official journal of theAmerican Academy of Neurology. Journal website: Neurology.org/NN, AANwebsite: AAN.com

Copyright and Permission Information: Please go to the journal website(www.neurology.org/nn) and click the Permissions tab for the relevant article.Alternatively, send an email to healthpermissions@wolterskluwer.com. Generalinformation about permissions can be found here: https://www.lww.com/journal-permission.

Disclaimer: Opinions expressed by the authors and advertisers are notnecessarily those of the American Academy of Neurology, its affiliates, or ofthe Publisher. The American Academy of Neurology, its affiliates, and thePublisher disclaim any liability to any party for the accuracy, completeness,efficacy, or availability of the material contained in this publication (includingdrug dosages) or for any damages arising out of the use or non-use of any of thematerial contained in this publication.

Advertising Sales Representatives: Wolters Kluwer, 333 Seventh Avenue, NewYork, NY 10001. Contacts: Eileen Henry, tel: 732-778-2261, fax: 973-215-2485,eileen.henry@wolterskluwer.com and in Europe: Craig Silver, tel: +44 7855062 550 or e-mail: craig.silver@wolterskluwer.com.

Careers & Events: Monique McLaughlin, Wolters Kluwer, Two CommerceSquare, 2001 Market Street, Philadelphia, PA 19103, tel: (215)-521- 8468, fax:215-521-8801; monique.mclaughlin@wolterskluwer.com.

Reprints: Meredith Edelman, Commercial Reprint Sales, Wolters Kluwer,Two Commerce Square, 2001 Market Street, Philadelphia, PA 19103, tel:215-356-2721; meredith.edelman@wolterskluwer.com; reprintsolutions@wolterskluwer.com.

Special projects: US & Canada: Alan Moore, Wolters Kluwer, Two CommerceSquare, 2001 Market Street, Philadelphia, PA 19103, tel: 215-521-8638,alan.moore@wolterskluwer.com. International: Andrew Wible, Senior Manager,Rights, Licensing, and Partnerships, Wolters Kluwer, translationrights@wolterskluwer.com.

A peer-reviewed clinical and translational neurology open access journal Neurology.org/NN

Neurology® Neuroimmunology & Neuroinflammation

EditorJosep O. Dalmau, MD, PhD

Deputy EditorScott S. Zamvil, MD, PhD, FAAN

Associate EditorsMichael Heneka, MDDennis Kolson, MD, PhDFriedmann Paul, MD

Editorial BoardRohit Aggarwal, MD, MSSergio E. Baranzini, PhDSusanne Benseler, MDJeffrey L. Bennett, MD, PhD, FAANSeverine Boillee, PhDMatthijs C. Brouwer, MD, PhDWolfgang Bruck, MDDavid B. Clifford, MD, FAANRussell C. Dale, MBChB, MRCP, PhDOscar H. Del Brutto, MD, FAANThomas G. Forsthuber, MDKazuo Fujihara, MDJeffrey M. Gelfand, MD, MAS, FAANJoseph El Khoury, MDMarkus P. Kummer, PhD

Jun Li, MD, PhDLin Mei, MD, PhDAndrew McKeon, MDChristopher Power, MDRichard M. Ransohoff, MDChristine Stadelmann, MDIsrael Steiner, MDLawrence Steinman, MDJesper Tegner, PhD, MScSilvia N. Tenembaum, MDMaarten J. Titulaer, MD, PhDAri Waisman, PhDHugh J. Willison, MBBS, PhDGregory F. Wu, MD, PhD

Neurology® Journals

Editor-in-ChiefRobert A. Gross, MD, PhD, FAAN

Deputy EditorBradford B. Worrall, MD, MSc, FAAN

Section Editors

BiostatisticsRichard J. Kryscio, PhDSue Leurgans, PhDV. Shane Pankratz, PhD

Classification of Evidence EvaluationsGary S. Gronseth, MD, FAAN

Equity, Diversity, and Inclusion (EDI)Roy H. Hamilton, MD, MS, FAANHolly E. Hinson, MD, MCR, FAAN

PodcastsStacey L. Clardy, MD, PhDJeffrey B. Ratliff, MD, Deputy Podcast Editor

OmbudsmanDavid S. Knopman, MD, FAAN

Scientific Integrity AdvisorRobert B. Daroff, MD, FAAN

Classification of Evidence Review TeamMelissa J. Armstrong, MDRichard L. Barbano, MD, PhD, FAANRichard M. Dubinsky, MD, MPH, FAANJeffrey J. Fletcher, MD, MScGary M. Franklin, MD, MPH, FAANDavid S. Gloss II, MD, MPH&TMJohn J. Halperin, MD, FAANJason Lazarou, MSc, MDSteven R. Messe, MD, FAANPushpa Narayanaswami, MBBS, DM, FAANAlex Rae-Grant, MD

Vision Neurology® Neuroimmunology &Neuroinflammation will be the premierpeer-reviewed journal in the fields ofneuroimmunology and neuroinflammation.

Mission Neurology: Neuroimmunology &Neuroinflammation will provide neurologistsand clinical research scientists withoutstanding peer-reviewed articles, editorials,and reviews to enhance patient care andfacilitate basic and translational research.

EditorialInquiries

Tel: 612-928-6400Toll-free: 800-957-3182 (US)Fax: 612-454-2748nnnjournal@neurology.org

StayConnected

facebook.com/NeurologyNN

twitter.com/greenjournal

youtube.com/user/NeurologyJournal

2019;6; Neurol Neuroimmunol Neuroinflamm 6 (5)

This information is current as of January 1, 2019

ServicesUpdated Information &

http://nn.neurology.org/content/6/5.full.htmlincluding high resolution figures, can be found at:

Supplementary Material http://nn.neurology.org/content/suppl/2019/09/10/6.5.DC1

Supplementary material can be found at:

  Permissions & Licensing

http://nn.neurology.org/misc/about.xhtml#permissionsits entirety can be found online at:Information about reproducing this article in parts (figures,tables) or in

  Reprints

http://nn.neurology.org/misc/addir.xhtml#reprintsusInformation about ordering reprints can be found online:

rights reserved. Online ISSN: 2332-7812.Published since April 2014, it is an open-access, online-only, continuous publication journal. Copyright . All

is an official journal of the American Academy of Neurology.Neurol Neuroimmunol Neuroinflamm